GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Small and Large Bowel/A value of D-dimer in acute arterial mesenteric ischemia
71

A value of D-dimer in acute arterial mesenteric ischemia

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated September 1, 2025

In acute arterial occlusive mesenteric ischemia (AOMI), baseline serum D-dimer levels hold significant prognostic value. The study found that elevated D-dimer levels were strongly associated with both short-term (30-day) and long-term (1-year) mortality. Non-survivors had markedly higher D-dimer levels compared to survivors (4.8 mg/L vs. 1.5 mg/L, p < 0.001). Elevated D-dimer reflects underlying hypercoagulability, endothelial dysfunction, and systemic inflammation, which are characteristic of severe disease progression in AOMI.

Optimal cutoff values for D-dimer were identified to predict mortality outcomes effectively. For 30-day mortality, the cutoff was 0.578 mg/L (82.8% sensitivity, 75.0% specificity), while for 1-year mortality, the threshold was 0.516 mg/L (90.9% sensitivity, 60.7% specificity). Patients with D-dimer levels above these cutoffs had significantly lower survival probabilities, confirmed through Kaplan-Meier survival analysis.

These findings suggest that measuring D-dimer within 24 hours of diagnosis can alert clinicians to critical disease severity, enabling timely interventions such as anticoagulation therapy or surgical consultation. Elevated D-dimer levels serve as independent predictors of mortality and are valuable in risk stratification for AOMI patients, improving clinical management and potentially survival outcomes.

Related Q&A

72

IBS-Specific IgG ELISA-Based Elimination Diet in IBS

The IBS-specific IgG ELISA-based elimination diet is a personalized dietary intervention designed to address food sensitivities in individuals with irritable bowel syndrome (IBS). This approach leverages an IgG...

73

TEDDY Study - Dietary Supplements, reduces Celiac Disease Risk

The TEDDY study primarily investigated dietary factors, focusing on dietary fiber intake rather than supplements, in relation to celiac disease risk among genetically predisposed children. It followed 6,520...

74

Microbiome-Directed Therapy for Malnutrition

Microbiome-directed therapy for malnutrition represents a groundbreaking approach to addressing childhood undernutrition by targeting the gut microbiome, a critical determinant of health and growth outcomes. Traditional treatments, such...

75

Imaging findings of IBS patients

Imaging studies have revealed several significant findings in patients with irritable bowel syndrome (IBS). These findings span both abdominal and brain imaging, shedding light on the structural and...

76

Microbiota and IBD-C

Constipation-predominant irritable bowel syndrome (IBS-C) is a subtype of IBS characterized by chronic constipation, abdominal discomfort, and altered bowel habits. The study you referenced explored the relationship between...

77

Risk of IBD in IBS patients

Irritable bowel syndrome (IBS) is linked to an increased long-term risk of developing inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD). A large study...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer